Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2016-11-23 | Bruce A. Hanna, Ph.D., is nominated as an independent member of the Board of Directors and will serve on the Audit, Nominating and Corporate Governance, and the Compensation Committee. It is expected he will serve as Chairman of the Nominating and Corporate Governance Committee. He is currently a Clinical Professor of Pathology and Clinical Professor of Microbiology at the New York University School of Medicine, and Adjunct Professor of Basic Science at New York University College of Dentistry, Adjunct Professor of Biology, Long Island University. From 2006 to 2015, he served on the ASM International Committee and WHO Global Committee, from 2000-2012 he served as an Editor of Clinical Microbiology Reviews, and 1982-2008 was Director of Clinical Microbiology, Immunology, and 2008-2010 was Interim Director of Pathology, Bellevue Hospital Center. Dr. Hanna, Ph.D. earned a Bachelor of Science in Biology from Saint Bonaventure University, a Masters in Science in Microbiology from Northeastern University, and a Ph.D. in Microbiology from Saint John27s University. Dr. Hanna27s post-doctorate work in Clinical Microbiology was at Mt. Sinai Hospital. We believe that Dr. Hanna27s qualifications to serve on our Board and its committees are demonstrated by his professional background, experience in the healthcare field, including his academic background and technical experience. |
2017-11-22 | BRUCE A. HANNA, Ph.D., has been a director of the Company since January 2017. He is currently a member of the Company’s Audit, Compensation and Nominating and Corporate Governance Committees and is the chairman of the Nominating and Corporate Governance Committee. |
2018-11-21 | Bruce A. Hanna, Ph.D., has been a director of the Company since January 2017. He is currently a member of the Company’s Audit, Compensation and Nominating and Corporate Governance Committees and is the chairman of the Nominating and Corporate Governance Committee. |
Data sourced from SEC filings. Last updated: 2025-08-30